Engineered herpes simplex viruses efficiently infect and kill CD133+ human glioma xenograft cells that express CD111.
J. Neurooncol., Nov;95(2):199-209 (2009)
Herpesvirus vectors for therapy of brain tumors.
Open Virol J., 4:103-8 (2010)
Ganciclovir transiently attenuates murine cytomegalovirus-associated renal allograft inflammation.
Transplantation., Oct;92(7):759-66 (2011)
Strategies for the rapid construction of conditionally-replicating HSV-1 vectors expressing foreign genes as anticancer therapeutic agents.
Mol. Pharm., Feb;8(1):44-9 (2011)
Human herpesviridae methods of natural killer cell evasion.
Adv Virol., 2012:359869 (2012)
The herpes simplex virus type 1 U(S)11 protein interacts with protein kinase R in infected cells and requires a 30-amino-acid sequence adjacent to a kinase substrate domain.
J. Virol., Mar;76(5):2029-35 (2002)
Human cytomegalovirus TRS1 and IRS1 gene products block the double-stranded-RNA-activated host protein shutoff response induced by herpes simplex virus type 1 infection.
J. Virol., Jul;79(14):8707-15 (2005)
Serial passage through human glioma xenografts selects for a Deltagamma134.5 herpes simplex virus type 1 mutant that exhibits decreased neurotoxicity and prolongs survival of mice with experimental brain tumors.
J. Virol., Aug;80(15):7308-15 (2006)
Ulceroglandular tularemia in a nonendemic area.
South. Med. J., Mar;100(3):304-8 (2007)
New therapeutic approaches to the alphaherpesvirus infections.
J. Antimicrob. Chemother., Feb;39(2):119-28 (1997)
Hypoxia Moderates Î³(1)34.5-Deleted Herpes Simplex Virus Oncolytic Activity in Human Glioma Xenoline Primary Cultures.
Transl Oncol., Jun;5(3):200-7 (2012)
Acyclovir-resistant chronic verrucous vaccine strain varicella in a patient with neuroblastoma.
Pediatr. Infect. Dis. J., Oct;27(10):946-8 (2008)
The herpes simplex virus US11 protein effectively compensates for the gamma1(34.5) gene if present before activation of protein kinase R by precluding its phosphorylation and that of the alpha subunit of eukaryotic translation initiation factor 2.
J. Virol., Nov;72(11):8620-6 (1998)